12/08/2018

IST has moved!

ImmunoSite Technologies has transferred to Miami-Dade County!  Please note the new addresses and effective dates below: Mailing Address  (Effective Date: December 1, 2018): P.O. Box 165937, Miami, FL 33116, USA Shipping Address (Effective Date: December 10, 2018): 4981 SW 74 Court, Miami, FL 33155, USA Share this:

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


11/01/2011

ImmunoSite Technologies Allies with Goodwin Biotechnology Increasing Capabilities

Tags:

Working together, ImmunoSite Technologies and Goodwin Biotechnology companies offer enhanced abilities to develop, test and manufacture biopharmaceuticals

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


09/27/2011

ImmunoSite Technologies Allies with Immudex for More Effective T Cell Response Monitoring

Tags: , , , ,

Working together, companies offer enhanced abilities to monitor immunotherapy response in vaccine and drug studies.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


12/07/2010

GLP Testing Services

A Commitment to Ensure Compliance The entire IST organization operates with a full quality system compliant with GLP guidelines and relevant international safety regulatory requirements. IST’s “state-of-the-art” facilities for immune monitoring, cell mediated immunity, particle testing, automation, and particle characterization, meet cGLP standards, and are in the process of obtaining CLIA certification. Key to meeting cGLP […]

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading